On this Guidance Document (new)
CLOSED Opened on 8/28/2023 and Ended on 9/27/2023
36 comments
Comment Title | Commenter | |
---|---|---|
Please don't allow new guidelines to pass for weight loss medications | Anonymous (220414) | 9/27/23 9:26 pm |
Please don't restrict access! | Patricia M Nece | 9/27/23 1:15 pm |
please do not restrict | laura bounds | 9/27/23 12:21 pm |
Patient access to anti-obesity medications | Obesity Action Coalition | 9/27/23 7:35 am |
Please do not restrict | Anonymous (220401) | 9/26/23 9:34 am |
GLP criteria | Dr. Nakeshia Lynn Mouzon | 9/26/23 9:10 am |
Oppose adding further restrictions | Anonymous (220377) | 9/21/23 10:19 pm |
Weight Loss Medication Restrictions | Anonymous (220374) | 9/21/23 3:30 pm |
Wegovy appeal | Esra Gokturk NP | 9/21/23 1:35 pm |
Wegovy Limitations | Patricia Williamson, AGPCNP-BC | 9/21/23 1:32 pm |
Obesity Medicine | Amy Vick | 9/21/23 11:22 am |
Wegovy | Anonymous (220366) | 9/21/23 10:57 am |
Do not make treating this chronic deadly disease harder to treat | S. Marshall, NP | 9/21/23 10:19 am |
Proposed changes are not inline with current evidence based literature and recommendations | Nathaniel Sann | 9/21/23 9:30 am |
weight loss medication restrictions | Sommer Knittig, M.D. | 9/18/23 10:27 pm |
Wegovy limitations | Carrie Schaefer, CVHS | 9/18/23 1:15 pm |
Increase in requirements Wegovy | Anonymous (220350) | 9/18/23 11:24 am |
Importance of medicaiton access for obesity treatment | Dr. Pamela Brandt | 9/15/23 12:33 pm |
weight loss medication restrictions | Sentara Medical Group | 9/15/23 6:09 am |
Wegovy access | Greg McClanahan | 9/14/23 8:44 pm |
Keep Current Access to Wegovy | Anonymous (220333) | 9/14/23 5:58 pm |
Opposition-Proposed Changes to DMAS Prior Authorization Requirements | Dr. Catherine Varney DO, Obesity Medicine Director UVA Health | 9/14/23 11:49 am |
Weight Loss Medication Criteria | Chesapeake Weight Loss | 9/14/23 11:40 am |
Don’t change criteria | Tiffany Gibson | 9/14/23 10:36 am |
Don’t change the criteria | Anonymous (220323) | 9/14/23 9:47 am |
Anti-Obesity Medications | Michael W. Jones, DO, MBA, FAAFP, Dipl. ABOM, CCHP | 9/13/23 2:04 pm |
GLP-1 medication | Dr Joshua A. Yeary | 9/12/23 10:01 pm |
Wegovy | Highlander Family Medicine | 9/11/23 10:22 am |
Changing requirements for GLP-1 | Susan Clapp, DNP | 9/9/23 4:13 pm |
Please reconsider the proposed barriers to effective GLP1 agonist use for the treatment of obesity | Susan Wolver, MD | 9/9/23 3:14 pm |
Importance of Obesity meds | Catherine Slusher, MD | 9/8/23 1:57 pm |
Weight Loss Management Drugs | Anonymous (220174) | 9/7/23 3:36 pm |
Weight Loss Management Drugs | Lisa Cullen, LPN | 9/7/23 2:24 pm |
Opposition to proposed changes | Katie George, DNP | 9/7/23 1:50 pm |
FNP | Shauntell Kline FNP | 9/7/23 12:22 pm |
Importance of GLP1Agonist medication access to the medicaid population | Dr Daphne Bryan | 9/3/23 12:42 pm |
Trouble posting comments? These pages have been tested with multiple versions of all the major browsers.
If you have trouble: (1) try another computer if you have access to one, (2) try another browser if your computer has one installed (3) contact
Town Hall support staff for assistance.